Aurobindo could face pressure after USFDA action on a plant
The stock jumped 21.4 per cent on February 19, the most in a decade, a day after Aurobindo said that it had received the VAI status, which enables a pharma company to undertake corrective action.from Markets-Economic Times https://ift.tt/32jmZM8
Post a Comment